Exterior view of the new University Heart and Vascular Center Hamburg
Press release

Siemens Healthineers equips UKE's new University Heart and Vascular Center with state-of-the-art medical technology

Published on May 28, 2026
  • Medical imaging technology for intervention suites (cardiac catheterization laboratories), hybrid laboratories as well as hybrid operating rooms and the Cardiovascular Imaging Center 
  • Patients benefit from higher quality of care

Siemens Healthineers installed state-of-the-art medical imaging technology for the recently opened Heart and Vascular Center at the University Medical Center Hamburg-Eppendorf (UKE). In addition to the 13 angiography systems for all cardiology and surgical specialist groups, the scope of supply included a photon-counting computed tomography scanner, a high-end 3-Tesla magnetic resonance tomograph and an X-ray imaging station. Siemens Healthineers will use it to equip all intervention suites (cardiac catheterization laboratories), hybrid rooms and the Cardiovascular Imaging Center. The focus is on the combination of medical expertise and state-of-the-art imaging technology. Thanks to the innovative equipment, procedures can be carried out even more precisely, gently and efficiently. At the same time, patients benefit from shorter examination times, improved treatment decisions and an overall higher quality of care. Building on this, a long-term strategic research partnership is to be established with the UKE that addresses joint fields of innovation and clinical research projects in cardiology, radiology and data-driven medicine. 

The new building for the existing University Heart and Vascular Center offers space for 379 beds, nine operating theatres, three of which are hybrid operating theatres, ten cardiac catheterisation laboratories and a cardiovascular imaging centre with CT, MRI and X-rays. The new building offers excellent conditions for top-class university medicine. In the future, adults and children will benefit from this in the diagnosis and treatment of cardiovascular diseases. Siemens Healthineers' strategic focus is on the increasing number of non-communicable diseases worldwide, such as stroke, neurodegenerative diseases, cardiovascular diseases and cancer. Three quarters of all deaths today are due to these diseases. Siemens Healthineers supports its customers around the globe in meeting this challenge.

Siemens Healthineers 2026

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.